232 related articles for article (PubMed ID: 14998776)
1. Xeroderma pigmentosum: from genetics to hopes and realities of cutaneous gene therapy.
Magnaldo T
Expert Opin Biol Ther; 2004 Feb; 4(2):169-79. PubMed ID: 14998776
[TBL] [Abstract][Full Text] [Related]
2. Genetic correction of DNA repair-deficient/cancer-prone xeroderma pigmentosum group C keratinocytes.
Arnaudeau-Bégard C; Brellier F; Chevallier-Lagente O; Hoeijmakers J; Bernerd F; Sarasin A; Magnaldo T
Hum Gene Ther; 2003 Jul; 14(10):983-96. PubMed ID: 12869216
[TBL] [Abstract][Full Text] [Related]
3. Xeroderma pigmentosum: from symptoms and genetics to gene-based skin therapy.
Magnaldo T; Sarasin A
Cells Tissues Organs; 2004; 177(3):189-98. PubMed ID: 15388993
[TBL] [Abstract][Full Text] [Related]
4. Retrovirus-mediated DNA repair gene transfer into xeroderma pigmentosum cells: perspectives for a gene therapy.
Zeng L; Sarasin A; Mezzina M
Cell Biol Toxicol; 1998 Mar; 14(2):105-10. PubMed ID: 9553721
[TBL] [Abstract][Full Text] [Related]
5. Complementation assays adapted for DNA repair-deficient keratinocytes.
Fréchet M; Bergoglio V; Chevallier-Lagente O; Sarasin A; Magnaldo T
Methods Mol Biol; 2006; 314():9-23. PubMed ID: 16673870
[TBL] [Abstract][Full Text] [Related]
6. Functional retroviral vector for gene therapy of xeroderma pigmentosum group D patients.
Carreau M; Quilliet X; Eveno E; Salvetti A; Danos O; Heard JM; Mezzina M; Sarasin A
Hum Gene Ther; 1995 Oct; 6(10):1307-15. PubMed ID: 8590735
[TBL] [Abstract][Full Text] [Related]
7. Reconstruction of DNA repair-deficient xeroderma pigmentosum skin in vitro: a model to study hypersensitivity to UV light.
Bernerd F; Asselineau D; Frechet M; Sarasin A; Magnaldo T
Photochem Photobiol; 2005; 81(1):19-24. PubMed ID: 15369409
[TBL] [Abstract][Full Text] [Related]
8. [Xeroderma pigmentosum: children of the moon].
Herouy Y; Krutmann J; Norgauer J; Schöpf E
J Dtsch Dermatol Ges; 2003 Mar; 1(3):191-8. PubMed ID: 16285494
[TBL] [Abstract][Full Text] [Related]
9. Clues to epidermal cancer proneness revealed by reconstruction of DNA repair-deficient xeroderma pigmentosum skin in vitro.
Bernerd F; Asselineau D; Vioux C; Chevallier-Lagente O; Bouadjar B; Sarasin A; Magnaldo T
Proc Natl Acad Sci U S A; 2001 Jul; 98(14):7817-22. PubMed ID: 11438733
[TBL] [Abstract][Full Text] [Related]
10. DNA damage and gene therapy of xeroderma pigmentosum, a human DNA repair-deficient disease.
Dupuy A; Sarasin A
Mutat Res; 2015 Jun; 776():2-8. PubMed ID: 26255934
[TBL] [Abstract][Full Text] [Related]
11. Xeroderma pigmentosum--bridging a gap between clinic and laboratory.
Moriwaki S; Kraemer KH
Photodermatol Photoimmunol Photomed; 2001 Apr; 17(2):47-54. PubMed ID: 11338401
[TBL] [Abstract][Full Text] [Related]
12. Xeroderma pigmentosum clinical practice guidelines.
Moriwaki S; Kanda F; Hayashi M; Yamashita D; Sakai Y; Nishigori C;
J Dermatol; 2017 Oct; 44(10):1087-1096. PubMed ID: 28771907
[TBL] [Abstract][Full Text] [Related]
13. Complementation of the DNA repair deficiency in human xeroderma pigmentosum group a and C cells by recombinant adenovirus-mediated gene transfer.
Muotri AR; Marchetto MC; Zerbini LF; Libermann TA; Ventura AM; Sarasin A; Menck CF
Hum Gene Ther; 2002 Oct; 13(15):1833-44. PubMed ID: 12396616
[TBL] [Abstract][Full Text] [Related]
14. Clinical, genetic and DNA repair studies on a consecutive series of patients with xeroderma pigmentosum.
Pawsey SA; Magnus IA; Ramsay CA; Benson PF; Giannelli F
Q J Med; 1979 Apr; 48(190):179-210. PubMed ID: 504548
[TBL] [Abstract][Full Text] [Related]
15. Xeroderma pigmentosum.
Norgauer J; Idzko M; Panther E; Hellstern O; Herouy Y
Eur J Dermatol; 2003; 13(1):4-9. PubMed ID: 12609773
[TBL] [Abstract][Full Text] [Related]
16. Differential behaviors toward ultraviolet A and B radiation of fibroblasts and keratinocytes from normal and DNA-repair-deficient patients.
Otto AI; Riou L; Marionnet C; Mori T; Sarasin A; Magnaldo T
Cancer Res; 1999 Mar; 59(6):1212-8. PubMed ID: 10096550
[TBL] [Abstract][Full Text] [Related]
17. Spotlight on 'xeroderma pigmentosum'.
Fassihi H
Photochem Photobiol Sci; 2013 Jan; 12(1):78-84. PubMed ID: 23132518
[TBL] [Abstract][Full Text] [Related]
18. Xeroderma pigmentosum and the role of UV-induced DNA damage in skin cancer.
van Steeg H; Kraemer KH
Mol Med Today; 1999 Feb; 5(2):86-94. PubMed ID: 10200950
[TBL] [Abstract][Full Text] [Related]
19. Functional lentiviral vectors for xeroderma pigmentosum gene therapy.
Marchetto MC; Correa RG; Menck CF; Muotri AR
J Biotechnol; 2006 Dec; 126(4):424-30. PubMed ID: 16857285
[TBL] [Abstract][Full Text] [Related]
20. Preclinical corrective gene transfer in xeroderma pigmentosum human skin stem cells.
Warrick E; Garcia M; Chagnoleau C; Chevallier O; Bergoglio V; Sartori D; Mavilio F; Angulo JF; Avril MF; Sarasin A; Larcher F; Del Rio M; Bernerd F; Magnaldo T
Mol Ther; 2012 Apr; 20(4):798-807. PubMed ID: 22068429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]